Clin2Atlas
AtlasMental health & substance useMental disorders

Attention-deficit/hyperactivity disorder

1SymptomaticAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251998 — Modafinil approved (FDA)2001 — Dexmethylphenidate approved (FDA)2002 — Atomoxetine approved (FDA)2007 — Lisdexamfetamine approved (FDA)2007 — Armodafinil approved (FDA)2015 — Idebenone approved (FDA)2019 — Solriamfetol approved (FDA)2021 — Viloxazine approved (FDA)2021 — Serdexmethylphenidate approved (FDA)
1998: Drug approval — Modafinil approved (FDA). 2001: Drug approval — Dexmethylphenidate approved (FDA). 2002: Drug approval — Atomoxetine approved (FDA). 2007: Drug approval — Lisdexamfetamine approved (FDA). 2007: Drug approval — Armodafinil approved (FDA). 2015: Drug approval — Idebenone approved (FDA). 2019: Drug approval — Solriamfetol approved (FDA). 2021: Drug approval — Viloxazine approved (FDA). 2021: Drug approval — Serdexmethylphenidate approved (FDA)

What's being tested now

2002: 1 trials started2008: 1 trials started2013: 1 trials started2014: 1 trials started2016: 5 trials started2017: 1 trials started2018: 5 trials started2019: 3 trials started2020: 5 trials started2021: 8 trials started2022: 18 trials started2023: 24 trials started2024: 58 trials started2025: 75 trials started2026: 72 trials started20102020202675

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 262 active Attention Deficit Disorder trials on Clin2 →

Related

SchizophreniaBipolar disorderAnxiety disordersAutism spectrum disordersConduct disorderIdiopathic developmental intellectual disabilityOther mental disorders

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.